EUROPEAN UROLOGY
Scope & Guideline
Unveiling the latest breakthroughs in urology.
Introduction
Aims and Scopes
- Clinical Research in Urology:
The journal publishes original clinical research that advances the understanding and treatment of urological diseases, including prostate cancer, bladder cancer, and renal cell carcinoma. This includes studies on surgical techniques, medical therapies, and the integration of new technologies in clinical practice. - Guidelines and Best Practices:
The journal is a key outlet for the European Association of Urology (EAU) guidelines, providing critical appraisals and updates that help shape clinical practices across Europe and beyond. - Innovative Technologies and Techniques:
Research on novel surgical techniques, robotic surgeries, and minimally invasive procedures is a significant focus, showcasing advancements that improve patient outcomes and reduce complications. - Biomarkers and Genomics:
The journal highlights studies on biomarkers in urology, particularly those related to cancer diagnosis, prognosis, and treatment response, including genetic and epigenetic factors influencing urological cancers. - Patient-Centered Research:
A growing emphasis on patient-reported outcomes, quality of life assessments, and the psychological aspects of urological health informs the journal's commitment to holistic patient care. - Translational Research:
Translational studies that bridge basic science and clinical application, including the investigation of immunotherapy and targeted therapies, are essential components of the journal's scope.
Trending and Emerging
- Artificial Intelligence and Digital Health:
The integration of AI in diagnostics, treatment planning, and patient management is rapidly gaining traction, with increasing numbers of studies exploring its potential in urology. - Personalized Medicine:
Research focusing on personalized approaches to treatment based on genetic, biomarker, and individual patient data is on the rise, particularly in the context of prostate and bladder cancer. - Minimally Invasive Techniques:
There is a significant trend towards minimally invasive surgeries, including robotic-assisted procedures and novel techniques that improve patient recovery times and outcomes. - Immunotherapy and Targeted Therapies:
As immunotherapy continues to evolve, research on its application in urological cancers, particularly bladder and renal cell carcinoma, is increasingly prominent in the journal. - Patient-Reported Outcomes and Quality of Life:
A growing body of literature is dedicated to understanding the impact of urological conditions and treatments on patients' quality of life, emphasizing the importance of patient-centered care. - Microbiome Research:
Emerging studies on the role of the urinary microbiome in health and disease are gaining interest, particularly in relation to urinary tract infections and bladder health.
Declining or Waning
- Traditional Open Surgery Techniques:
There is a noticeable decline in publications related to traditional open surgical techniques as robotic and minimally invasive procedures gain preference in clinical practice. - General Urology Topics:
Papers that cover broad, non-specific urology topics are becoming less common, with a shift towards more specialized research that addresses specific diseases or innovative treatments. - Historical Perspectives:
Although historical analyses have their value, the journal has seen a reduction in articles that focus on historical perspectives of urology, likely due to the increasing demand for cutting-edge research and clinical advancements. - Non-Evidence Based Practices:
There is a growing emphasis on evidence-based practices, leading to a decline in articles that do not clearly demonstrate clinical efficacy or are based on anecdotal evidence.
Similar Journals
Urology Research and Practice
Pioneering research for enhanced urological care.Urology Research and Practice, published by AVES in Turkey, is an essential open-access journal dedicated to advancing the field of urology. With its inaugural issues released in 2023, the journal aims to disseminate cutting-edge research, innovative practices, and insightful clinical studies pertinent to urology, thereby fostering knowledge and collaboration among researchers, healthcare professionals, and students alike. Currently indexed in Scopus, it ranks Q3 in the urology category, reflecting its growing impact evidenced by a 47th percentile ranking in the Medicine Urology field. The journal not only serves as a platform for exceptional scholarly work but also emphasizes accessibility and inclusivity in scientific communication, allowing for a broader dissemination of urological knowledge globally. Explore groundbreaking research and contribute to the evolving landscape of urology through Urology Research and Practice.
Journal of Clinical Urology
Bridging Research and Practice in Urological CareThe Journal of Clinical Urology, published by SAGE Publications Ltd, is a prominent academic platform dedicated to advancing the field of urology and surgical medicine. With an ISSN of 2051-4158 and an E-ISSN of 2051-4166, this journal has been pivotal in disseminating cutting-edge research since its inception in 2008 and is set to continue through 2024. Although categorized in the Q4 quartile for both Surgery and Urology, and positioned in the 24th and 22nd percentiles respectively according to Scopus rankings, the journal remains an essential resource for professionals, researchers, and students who seek to understand clinical developments and innovative practices in urological surgery. While the journal does not operate under an Open Access model, it provides critical insights and valuable findings that significantly impact healthcare practices and patient outcomes in the urology field.
BJU INTERNATIONAL
Elevating Research, Transforming PracticeBJU International is a prestigious academic journal specializing in the field of Urology, published by WILEY, one of the leading publishers in scientific literature. With an impressive impact factor and recognized as a Q1 journal in Urology for 2023, it ranks #7 out of 120 in the Scopus Medicine _ Urology category, placing it in the 94th percentile among its peers. Established in 1929 and with converged years from 1994 to 2024, BJU International provides a platform for groundbreaking research, clinical studies, and advancements in urological science. The journal is accessible in both print and online formats, catering to a global audience dedicated to enhancing urological practice and research. By fostering interdisciplinary dialogue and disseminating high-quality studies, BJU International plays a crucial role in advancing knowledge and improving patient care in the field of urology.
PROGRES EN UROLOGIE
Unveiling the Latest in Urological SciencePROGRES EN UROLOGIE is a renowned academic journal published by Elsevier Masson, Corp Off that focuses on the dynamic field of urology. With an ISSN of 1166-7087 and an E-ISSN of 2405-5131, this journal has been contributing to the scientific community since its inception in 1991 and continues to disseminate valuable research findings to urologists and medical professionals. As of 2023, it holds a distinguished position within the Q3 category in Urology, reflecting its commitment to publishing high-quality and impactful research—ranked 74th out of 120 in the Scopus Urology category, placing it in the 38th percentile. While it does not currently offer open access options, the journal remains an essential resource for researchers seeking to advance their understanding of the latest urological practices and innovations. Its contributions are vital in a rapidly evolving medical landscape, ensuring that both established and emerging issues in urology are thoroughly explored and discussed.
ARCHIVOS ESPANOLES DE UROLOGIA
Bridging Tradition and Innovation in UrologyARCHIVOS ESPANOLES DE UROLOGIA, published by INIESTARES, S.A., serves as a key academic resource for urology and related medical fields. With an impressive history dating back to 1945, this journal has evolved to address the ongoing advancements and challenges in the field of urology, making crucial contributions to medical knowledge and practice. Although classified in category quartile Q3 for Urology and Q4 for Medicine (miscellaneous), the journal's commitment to quality research is reflected in its diverse range of topics, which are geared toward practitioners, researchers, and students alike. While it does not currently operate under an open access model, the insights and findings presented in its articles are indispensable for anyone looking to deepen their understanding of urological medicine. With a Scopus rank of #84 out of 120 in Urology, this journal continues to be an essential platform for disseminating significant research and fostering academic dialogue in the Spanish medical community and beyond.
European Urology Oncology
Exploring the frontiers of urology and oncology for tomorrow's healthcare.European Urology Oncology is a premier academic journal dedicated to advancing the field of urological oncology through innovative research and interdisciplinary collaboration. Published by Elsevier and based in the Netherlands, this journal runs on the principles of providing high-quality, peer-reviewed content that meets the evolving needs of professionals in medicine, surgery, and oncology. With an impressive 2023 categorization in the Q1 quartiles across multiple disciplines including Medicine (Miscellaneous), Oncology, and Urology, the journal demonstrates its pivotal role in disseminating essential findings that enhance clinical practices. The E-ISSN of this journal is 2588-9311, ensuring accessibility to groundbreaking articles that influence treatment methodologies and patient outcomes. Researchers and professionals relying on the latest evidence in urology and oncology will find this journal essential for keeping abreast of cutting-edge developments and clinical insights that shape the future of healthcare.
BMC Urology
Championing Open Access for Urological ExcellenceBMC Urology is a premier open-access journal dedicated to advancing research in the field of urology, reproductive medicine, and miscellaneous aspects of medicine. Published by BMC since 2001 and based in the United Kingdom, this journal provides a platform for researchers, clinicians, and students to disseminate their findings and explore the latest innovations and advancements within these vital fields. With a notable impact factor and categorization in the Q2 quartile for various categories of medicine, BMC Urology stands as a reputable source, ranking 51st out of 120 in Urology and 44th out of 90 in Reproductive Medicine according to Scopus metrics. The journal fosters knowledge sharing through its open-access model, ensuring that research is accessible to all. As it converges from 2001 to 2024, BMC Urology continues to play a crucial role in shaping the landscape of urological research and providing invaluable insights into clinical practices.
Bladder Cancer
Advancing bladder cancer research for a healthier tomorrow.Bladder Cancer, published by IOS PRESS, is a premier open access journal dedicated to advancing the field of oncology and urology, with a specific focus on bladder cancer research and treatment. Established in 2015 and continuing through to 2024, this journal aims to disseminate high-quality, peer-reviewed research that contributes to the understanding, diagnosis, and management of bladder cancer, a critical area of concern in urological oncology. With a robust publication record now encompassing open access since 2023, Bladder Cancer ensures accessibility to vital research for clinicians, researchers, and scholars worldwide. The journal's rankings in Scopus reflect its commitment to excellence, holding a Q3 category in both oncology and urology, with Scopus ranks of #78 in Urology and #285 in Oncology, showcasing its growing influence in the scientific community. By fostering dialogue and innovation, Bladder Cancer serves as an essential resource for those committed to improving patient outcomes in bladder oncology.
Current Urology
Innovative Insights in Urology, Oncology, and Reproductive MedicineCurrent Urology, published by Lippincott Williams & Wilkins, is a leading journal dedicated to advancing the fields of urology, oncology, and reproductive medicine. With an ISSN of 1661-7649 and E-ISSN of 1661-7657, this journal has established itself as a valuable resource for researchers, practitioners, and students alike, providing peer-reviewed articles that contribute to the ongoing discourse and development of these critical specialties. Operating out of the United States, Current Urology ranks in the third quartile for oncology, reproductive medicine, and urology, reflecting its importance in the medical community. The journal’s focus on innovative research and clinical practice allows it to bridge gaps between theoretical understanding and practical application, enhancing patient care and outcomes. Although currently not an open-access journal, it offers a wealth of insights and findings that underpin contemporary urological practices and research. In an evolving medical landscape, Current Urology remains an essential platform for disseminating knowledge and fostering collaboration among experts in the field.
European Urology Open Science
Fostering Collaboration in Urology ResearchEuropean Urology Open Science is a premier open-access journal dedicated to advancing the field of urology through publishing high-quality, peer-reviewed research. Published by ELSEVIER in the Netherlands, this journal is recognized for its significant contribution to the medical community, boasting an impressive Q1 ranking in Urology for 2023, indicative of its influence and the quality of research it disseminates. With a focus on innovative studies and interdisciplinary approaches, the European Urology Open Science plays a pivotal role in fostering knowledge exchange and promoting clinical best practices. Researchers, professionals, and students alike benefit from its accessible research format, facilitating a broader dissemination of urological advancements. This journal embraces the Open Access model, ensuring that pioneering findings are readily available to the global scientific community, further enhancing collaboration and knowledge sharing within the field.